Zdrowie i gospodarka · 01/04/2026
Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute is contemplating the grant of an Exclusive Patent License to Perpetual Biosciences, Inc. for practicing inventions related to treating retinal degeneration.